no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A critical look at persistent problems in the diagnosis, staging and treatment of temporal bone carcinoma
|
Zanoletti, Elisabetta |
|
2015 |
41 |
10 |
p. 821-826 6 p. |
article |
2 |
Clinical characteristics of patients with relapsed multiple myeloma
|
Dimopoulos, Meletios A. |
|
2015 |
41 |
10 |
p. 827-835 9 p. |
article |
3 |
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU)
|
Sargos, Paul |
|
2015 |
41 |
10 |
p. 814-820 7 p. |
article |
4 |
Editorial Board
|
|
|
2015 |
41 |
10 |
p. IFC- 1 p. |
article |
5 |
From autonomy to community; new perspectives on tumorigenicity and therapy resistance
|
Skrbo, Nirma |
|
2015 |
41 |
10 |
p. 809-813 5 p. |
article |
6 |
Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review
|
Frederiks, C.N. |
|
2015 |
41 |
10 |
p. 935-950 16 p. |
article |
7 |
Identifying an optimal antiemetic regimen for patients receiving anthracycline and cyclophosphamide-based chemotherapy for breast cancer – An inspection of the evidence base informing clinical decision-making
|
Hutton, Brian |
|
2015 |
41 |
10 |
p. 951-959 9 p. |
article |
8 |
Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives
|
Mirghani, Haïtham |
|
2015 |
41 |
10 |
p. 844-852 9 p. |
article |
9 |
Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma – A systematic review
|
Clement, S.C. |
|
2015 |
41 |
10 |
p. 925-934 10 p. |
article |
10 |
Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron)
|
Rojas, Camilo |
|
2015 |
41 |
10 |
p. 904-913 10 p. |
article |
11 |
Mechanisms of lapatinib resistance in HER2-driven breast cancer
|
D’Amato, Valentina |
|
2015 |
41 |
10 |
p. 877-883 7 p. |
article |
12 |
PD-1 and PD-L1 blockade in gastrointestinal malignancies
|
Lote, Hazel |
|
2015 |
41 |
10 |
p. 893-903 11 p. |
article |
13 |
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy
|
Meng, Xiangjiao |
|
2015 |
41 |
10 |
p. 868-876 9 p. |
article |
14 |
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis
|
Perisanidis, C. |
|
2015 |
41 |
10 |
p. 960-970 11 p. |
article |
15 |
Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis
|
Nishijima, Tomohiro F. |
|
2015 |
41 |
10 |
p. 971-978 8 p. |
article |
16 |
Targeting immune checkpoints: New opportunity for mesothelioma treatment?
|
Marcq, Elly |
|
2015 |
41 |
10 |
p. 914-924 11 p. |
article |
17 |
The role of systemic therapy in the management of sinonasal cancer: A critical review
|
Bossi, Paolo |
|
2015 |
41 |
10 |
p. 836-843 8 p. |
article |
18 |
The use of combinations of monoclonal antibodies in clinical oncology
|
Henricks, Linda M. |
|
2015 |
41 |
10 |
p. 859-867 9 p. |
article |
19 |
Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer
|
Buttigliero, Consuelo |
|
2015 |
41 |
10 |
p. 884-892 9 p. |
article |
20 |
Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma
|
Ceresoli, Giovanni Luca |
|
2015 |
41 |
10 |
p. 853-858 6 p. |
article |